Related Experiment Video
Updated: Jul 31, 2026

Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation
Published on: January 15, 2011
Transforming growth factor-beta 1 is chemotactic for interleukin-2-activated natural killer cells
1Northeastern Ontario Regional Cancer Centre, Sudbury, Canada.
Abstract:
We examined the effect of transforming growth factor-beta 1 (TGF-beta 1) on the in vitro motility of interleukin-2-activated natural killer (IANK) cells. Low doses of TGF-beta 1 (0.01 or 0.1 ng/ml) are chemotactic for these cells as determined by modified Boyden chamber assay. IANK cells bind biotinylated TGF-beta suggesting that they express receptors for this cytokine. TGF-beta 1-induced IANK cell chemotaxis was inhibited by protein kinase C inhibitors, such as staurosporine and H7. The role of calcium mobilization in TGF-beta 1 activity was also examined; the inhibitor of intracellular Ca2+, TMB-8, inhibited TGF-beta 1-induced IANK cell chemotaxis. Supporting the role for Ca2+ mobilization is the ability of low doses of TGF-beta 1 to induce the recruitment of intracellular Ca2+ as determined by a fura-2-AM-loaded-cell assay.
Related Concept Videos
Mitogens and the Cell Cycle
TGF - β Signaling Pathway
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

